The blood-brain barrier in neuroimmunology: Tales of separation and assimilation
Open accessAbstract
Neuroimmunology is concerned with the relations between the central nervous and immune systems and with the mechanisms that drive those relations. The blood-brain barrier (BBB) employs mechanisms that both separate and connect these two systems. In fact, the relative immune privilege of the central nervous system (CNS) is largely attributable to the BBB's ability to prevent the unregulated exchange of immune cells and their secretions between the CNS and blood. Having separated the two systems, the BBB then participates in mechanisms that allow them to influence, communicate, and interact with one another. Likewise, the BBB itself is influenced by immune events that are occurring in the periphery and in the CNS so that these three components (the BBB, the immune system, and the CNS) form neuroimmune axes that adapt to physiological and pathological conditions. To date, four major themes have emerged by which the BBB participates in these neuroimmune axes. The first of these four, the formation of the barrier, acts to separate the immune and central nervous systems. The other three themes provide mechanisms for re-establishing communication: response of the BBB to immunomodulatory molecules (e.g., prostaglandins, cytokines, chemokines, nitric oxide) secreted by immune and CNS cells; the controlled, regulated exchange of chemokines, cytokines, and immune cells between the CNS and the blood (i.e., transport across the BBB); the secretion of immunomodulatory molecules by the BBB, often in a polarized fashion. Taken together, these mechanisms reveal the BBB to be a dynamic, interactive, and adaptable interface between the immune system and the CNS, separating them on the one hand and fostering their interactions on the other hand, adjusting to physiological changes, while being a target for disease processes. This review examines specific examples by which the BBB plays an interactive, defining role in neuroimmunology.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Active transporters on the blood-brain barrier move immunomodulatory molecules into and out of the CNS.
“Active transporters on the BBB move an array of immunomodulatory molecules into and out of the CNS (reviewed by Banks (2015)).”
From Sleep health: Reciprocal regulation of sleep and innate immunity (2017) · cites this paper as Banks, 2015
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 98 · Cited by 292
Research works printed but not linked: 3
- Macvilay S Fabry Z TGF· cytokine production by murine brain microvessel endothelial cells. Neural Notes 1997 3 21 23 10843741
- Nakaoke R Verma S Niwa M Dohgu S Banks WA Glucose-regulated blood-brain barrier transport of insulin: Pericyte-astrocyte-endothelial cell cross talk. International Journal of Neuroprotection and Neuroregeneration 2007 3 195 200
- Yu C Pan W Tu H Waters S Kastin AJ TNF activates MDR1 (P-glycoprotein) in cerebral microvascular endothelial cells. Cell Physiol Biochem 2007b 20 853 858 17982267
- Authors
- Banks, W. A.
- Affiliations
- University of Washington (US)
- Corresponding author
- Banks, W.A.
- ORCID
- Banks, W.A.
- Venue
- Brain, Behavior, and Immunity
- Publisher
- Elsevier BV
- Published
- 2015-02
- Volume
- 44
- Pages
- 1-8
- ISSN
- 0889-1591 (ISSN-L)
- PMC
- PMC4275374
- OpenAlex
- W2058148996
- Cited by
- 292
- References
- 98
- Citations by year
- 2026: 41 · 2025: 23 · 2024: 22 · 2023: 25 · 2022: 21 · 2021: 21 · 2020: 28 · 2019: 25 · 2018: 21 · 2017: 27 · 2016: 24 · 2015: 13 · 2014: 1
- FWCI
- 1.73
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Brain Behavior and Immunity (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Aging (R01AG029834, R01AG029839)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK083485)
- National Institute of Neurological Disorders and Stroke (NS051134)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- blood-brain barrier, neuroimmunology, immune privilege, central nervous system, immunomodulatory molecules, cytokines, chemokines, prostaglandins, nitric oxide, immune cell trafficking, barrier formation, neuroinflammation
- MeSH terms
- Animals, Blood-Brain Barrier, Humans, Nitric Oxide, Prostaglandins, Neuroimmunomodulation, Cytokines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review